COURTNEY MARTINEZ: Open Payments
NPI 1518394923 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 18 payments from 13 companies in 2025. Trend: 2023 $499 · 2024 $269 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 1 | $158 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Abbott Laboratories | 1 | $32 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Regeneron Pharmaceuticals, Inc. | 1 | $27 |
| BridgeBio Pharma, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: Barostim Neo System, Kerendia, LEQVIO, CARDIOMEMS, VERQUVO, NEXLETOL, EVKEEZA, Attruby.
Industry payments across TX — which companies pay providers there.
